Singular Health Group (ASX:SHG) Short-Term Debt: A$0.02 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:SHG Singular Health Group Ltd ASX:SHG
27 GF Score
Price A$0.22
GF Value A$0.11
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Singular Health Group Short-Term Debt?

Singular Health Group ASX:SHG -2.27% 27 Short-Term Debt is A$0.02 Mil as of Dec. 2025. GuruFocus rates ASX:SHG with a GF Score™ of 27/100 and a GF Value™ of A$0.11 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Singular Health Group's Short-Term Debt for the quarter that ended in Dec. 2025 was A$0.02 Mil.

Singular Health Group's quarterly Short-Term Debt stayed the same from Dec. 2024 (A$0.00 Mil) to Jun. 2025 (A$0.00 Mil) but then increased from Jun. 2025 (A$0.00 Mil) to Dec. 2025 (A$0.02 Mil).

Singular Health Group's annual Short-Term Debt declined from Jun. 2023 (A$4.01 Mil) to Jun. 2024 (A$0.22 Mil) and declined from Jun. 2024 (A$0.22 Mil) to Jun. 2025 (A$0.00 Mil).


Singular Health Group Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Singular Health Group Short-Term Debt Related Terms


Singular Health Group Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Singular Health Group's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Singular Health Group Short-Term Debt Chart

Singular Health Group Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Short-Term Debt
0.00 0.00 4.01 0.22 0.00

Singular Health Group Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.24 0.22 0.00 0.00 0.02
ASX:SHG
27GF Score
Singular Health Group Ltd ASX:SHG
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of A$0.02 Mil mean?
Singular Health Group (ASX:SHG) has a Short-Term Debt of A$0.02 Mil as of Dec. 2025.
Is Singular Health Group's Short-Term Debt too high?
Singular Health Group's current Short-Term Debt is A$0.02 Mil. Overall, Singular Health Group has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Singular Health Group's Short-Term Debt compare to VEEV and BTSG?
Singular Health Group's Short-Term Debt of A$0.02 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Singular Health Group's current Short-Term Debt is A$0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Singular Health Group stock overvalued right now?
Based on GuruFocus' analysis, Singular Health Group (ASX:SHG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.11, compared to a current price of A$0.22 — trading 95.5% above its estimated fair value. The current Short-Term Debt is A$0.02 Mil. Singular Health Group's overall GF Score™ is 27/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Singular Health Group (ASX:SHG), the current Short-Term Debt is A$0.02 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Singular Health Group (ASX:SHG) Overvalued in 2026?

Based on GuruFocus' analysis, Singular Health Group stock appears to be overvalued. The current stock price of A$0.22 is trading 95.5% above its estimated GF Value™ of A$0.11. GuruFocus considers Singular Health Group to be Significantly Overvalued.

Key valuation signals for ASX:SHG:

  • Short-Term Debt: A$0.02 Mil
  • GF Value™: A$0.11 vs. price of A$0.22 (95.5% above fair value)
  • GF Score™: 27/100 with 2 warning signs

No single metric tells the full story. See the ASX:SHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Singular Health Group Business Description

Address E3 and E4, 661 Newcastle Street, Leederville, WA, AUS, 6007
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.
27GF Score

Get the complete analysis for ASX:SHG

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.22
Price
A$0.11
GF Value